Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Phosphorylation of CRYAB induces a condensatopathy to worsen post–myocardial infarction left ventricular remodeling
Moydul Islam, … , Kartik Mani, Abhinav Diwan
Moydul Islam, … , Kartik Mani, Abhinav Diwan
Published February 11, 2025
Citation Information: J Clin Invest. 2025;135(7):e163730. https://doi.org/10.1172/JCI163730.
View: Text | PDF
Research Article Cardiology Cell biology

Phosphorylation of CRYAB induces a condensatopathy to worsen post–myocardial infarction left ventricular remodeling

  • Text
  • PDF
Abstract

Protein aggregates are emerging therapeutic targets in rare monogenic causes of cardiomyopathy and amyloid heart disease, but their role in more prevalent heart-failure syndromes remains mechanistically unexamined. We observed mislocalization of desmin and sarcomeric proteins to aggregates in human myocardium with ischemic cardiomyopathy and in mouse hearts with post–myocardial infarction ventricular remodeling, mimicking findings of autosomal-dominant cardiomyopathy induced by the R120G mutation in the cognate chaperone protein CRYAB. In both syndromes, we demonstrate increased partitioning of CRYAB phosphorylated on serine 59 to NP40-insoluble aggregate-rich biochemical fraction. While CRYAB undergoes phase separation to form condensates, the phosphomimetic mutation of serine 59 to aspartate (S59D) in CRYAB mimics R120G-CRYAB mutants with reduced condensate fluidity, formation of protein aggregates, and increased cell death. Conversely, changing serine to alanine (phosphorylation-deficient mutation) at position 59 (S59A) restored condensate fluidity and reduced both R120G-CRYAB aggregates and cell death. In mice, S59D CRYAB knockin was sufficient to induce desmin mislocalization and myocardial protein aggregates, while S59A CRYAB knockin rescued left ventricular systolic dysfunction after myocardial infarction and preserved desmin localization with reduced myocardial protein aggregates. 25-Hydroxycholesterol attenuated CRYAB serine 59 phosphorylation and rescued post–myocardial infarction adverse remodeling. Thus, targeting CRYAB phosphorylation-induced condensatopathy is an attractive strategy to counter ischemic cardiomyopathy.

Authors

Moydul Islam, David R. Rawnsley, Xiucui Ma, Walter Navid, Chen Zhao, Xumin Guan, Layla Foroughi, John T. Murphy, Honora Navid, Carla J. Weinheimer, Attila Kovacs, Jessica Nigro, Aaradhya Diwan, Ryan P. Chang, Minu Kumari, Martin E. Young, Babak Razani, Kenneth B. Margulies, Mahmoud Abdellatif, Simon Sedej, Ali Javaheri, Douglas F. Covey, Kartik Mani, Abhinav Diwan

×

Figure 7

Treatment with 25-HC reduces phosphorylation of CRYAB at S59 and alters the phase-separation characteristics of CRYAB-R120G.

Options: View larger image (or click on image) Download as PowerPoint
Treatment with 25-HC reduces phosphorylation of CRYAB at S59 and alters ...
(A and B) Representative immunoblots depicting total pS59-CRYAB, CRYAB, p62, and polyUb proteins in NP40-detergent (A) soluble and (B) insoluble fractions from neonatal rat cardiomyocytes (NRCMs) transduced with adenoviral CRYAB-R120G (MOI=10) for 90 hours and treated with 0, 10, 20, and 40 mM 25-HC for the final 72 hours. GAPDH and actin are shown as loading controls. (C) Representative immunofluorescence images of NRCMs treated in A. Arrows point to GFP-positive aggregates. (D–G) Quantitative assessment of pS59-CRYAB (D), total CRYAB (E), p62 (F), and polyUb protein (G) expression in NP-40 soluble and insoluble fractions from NRCMs treated in A. **P < 0.01 by t test. (H) Representative time-lapse images at t = 0 seconds, 100 seconds, 200 seconds, and 300 seconds after light activation in HEK293A cells transfected with OptoIDR constructs generated with CRYAB-R120G as the IDR protein and treated with diluent or 25-HC (40 mM). (I and J) Average number (I) and area (J) of condensates/cell at t = 0 versus t = 300 seconds in cells treated as in H. **P < 0.01 by t test. (K) Representative images demonstrating recovery of fluorescence after photobleaching in HEK 293A cells treated as in H. The area of photobleaching is marked with a dotted circle prior to (prebleach), and at 0, 100, 200, 300, 400, and 500 seconds (s) after photobleaching. (L) Quantitation of fluorescence recovery in condensates of CRYAB variants (as maximum minus immediately after photobleaching) as shown in K. *P < 0.05 by t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts